hoffman laroche inc said eli lilly and inc will pay royalties sale lilly human growth hormone humatrope part earlier reported licensing agreement between companies hoffman roche spokesman john doorley declined disclose amount royalty payments lilly has taken position respecting patent paying roylaties said doorley hopeful companies will respect position said roche licensee hormone research foundation patent for synthetic version human growth hormone last september roche and foundation sued genetech inc alleging genetech product protropin human growth hormone infringed hoffman patent for hormone last year genetech sales protropin were about mln dlrs david saks drug analyst with morgan olmstead kennedy and gardner new york said genetech and lilly product can each bring about mln dlrs sales annually companies developing human growth hormone include biotechnology general corp roche doorley said company had time started developing growth hormone but decided put its efforts into products reuter 